Difference between revisions of "Reviewable Unit (RPS)"
Joelfinkle (talk | contribs) |
Joelfinkle (talk | contribs) (Definition of Reviewable Unit) |
||
Line 2: | Line 2: | ||
==R1 Working Definition== | ==R1 Working Definition== | ||
− | Collection of one or more [[Submission Unit (RPS)| | + | Collection of one or more [[Submission Unit (RPS)|Submission Units]] that collectively become part of a [[Submission (RPS)|Submission]]. [not fully discussed] |
==ICH Equivalent== | ==ICH Equivalent== | ||
Line 14: | Line 14: | ||
For example, a veterinary medicine New Animal Drug Application (NADA) (marketing application) is constructed from the Investigational New Animal Drug Application (INADA). In the INADA process the sponsor creates reviewable units. These reviewable units are then compiled to be used as documentation for the marketing application. | For example, a veterinary medicine New Animal Drug Application (NADA) (marketing application) is constructed from the Investigational New Animal Drug Application (INADA). In the INADA process the sponsor creates reviewable units. These reviewable units are then compiled to be used as documentation for the marketing application. | ||
+ | |||
+ | ==Additional Regional Definitions and Synonyms== | ||
+ | |||
[[Category:RPS Glossary]] | [[Category:RPS Glossary]] |
Revision as of 17:18, 19 September 2008
This is a Glossary page
Contents
R1 Working Definition
Collection of one or more Submission Units that collectively become part of a Submission. [not fully discussed]
ICH Equivalent
none
BRIDG Term
Reviewable Unit (???) A discrete portion of a submission which is used to receive agreement. Once agreement is reached on all units within the submission the submission can then be approved.
For example, in a Modular pre-marketing application (PMA) several modules will be sent to the Food & Drug Administration (FDA). Each module will be agreed upon independently of other modules. The FDA then approves the submission based on compilation of all of the modules. These modules are reviewable units.
For example, a veterinary medicine New Animal Drug Application (NADA) (marketing application) is constructed from the Investigational New Animal Drug Application (INADA). In the INADA process the sponsor creates reviewable units. These reviewable units are then compiled to be used as documentation for the marketing application.